≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Chronic myeloid leukaemia [CML], BCR/ABL-positive

DOID PheWeb

CML

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 C92.1
Hospital discharge: ICD-9 2051
Cause of death: ICD-10 C92.1
Cause of death: ICD-9 2051

2 out of 7 registries used, show all original rules.

248

diagram downward connector

Check minimum number of events None

248

diagram downward connector

Include endpoints None

248

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

232

diagram downward connector
CML

Control definitions

Control exclude MYELOPROF

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 232 113 119
Unadjusted prevalence (%) 0.06 0.05 0.07
Mean age at first event (years) 57.02 55.94 58.04

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CML – Chronic myeloid leukaemia [CML], BCR/ABL-positive
GWS hits:

Survival analyses between endpoints

↥

Plot

before Chronic myeloid leukaemia [CML], BCR/ABL-positive
after Chronic myeloid leukaemia [CML], BCR/ABL-positive

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Chronic myeloid leukaemia [CML], BCR/ABL-positive

↥

Endpoint not on priority list, no data to show.